Paydirt
CL
Insider

Caroline Litchfield

EVP & CFO

Caroline Litchfield (EVP & CFO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Merck & Co., Inc. (MRK). The largest single filing was $5.0M of MRK (41,997 sh × $119.61, as filed), executed Feb 4.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Feb 4
Filed Feb 6

Median ADV $1.4B across their filed names

Open performance→
Volume by month
$5.0M$2.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2026 · sells $5.0M
Buys $0 Sells $5.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
MRK Merck & Co., Inc. MRK · 0 buys · 1 sell 1 filing
Recent filings
MRKSALE Merck & Co., Inc. View filing → $5.0M
41,997 sh × $119.61
Exec Feb 4
Filed Feb 6 · 5:30 PM ET